Filing Details
- Accession Number:
- 0001638599-17-000948
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-22 17:30:29
- Reporting Period:
- 2017-09-20
- Accepted Time:
- 2017-09-22 17:30:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1453687 | Selecta Biosciences Inc | SELB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1676906 | David Siewers | C/O Selecta Biosciences, Inc. 480 Arsenal Way Watertown MA 02472 | Cfo And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-09-20 | 2,194 | $0.63 | 2,194 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-09-20 | 2,194 | $20.00 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-09-20 | 14,230 | $0.63 | 14,230 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-09-20 | 14,230 | $20.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2017-09-20 | 2,194 | $0.00 | 2,194 | $0.63 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2017-09-20 | 14,230 | $0.00 | 14,230 | $0.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-09-06 | No | 4 | M | Direct | |
| 5,000 | 2021-02-16 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
- All shares underlying this option are fully vested.
Billionaire Hedge Funds
